XNCR
Xencor IncPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 25 ▲ Xencor reported financial results for Q4 and full year 2025, showing…
- Mar 4 ▼ Xencor Inc. announced that Alexion Pharmaceuticals disputes its obli…
- Mar 5 to Mar 6 ▼ 2 days of insider sells: $398.2K by 4 insiders, avg $11.18
- Apr 10 ▼ 1 insider sell $43.0K at $12.29
- May 5 ▲ Xencor reported final Phase 1 data for XmAb942, an anti-TL1A antibod…
- May 6 ▼ Xencor reported Q1 2026 revenue of $4.5M (down 86% YoY) and a net lo…
- Jun 15 to Jun 18 ▼ 2 days of insider sells: $379.1K by 5 insiders, avg $12.48
- Aug 5 ▲ Xencor reported Q2 2026 revenue of $51.2M (vs $18.9M consensus) and…
- Aug 14 ▼ Short interest jumps 25.1% to 14.19M
- Oct 15 ▲ Short interest falls 25.1% to 12.27M
- Oct 26 ▲ Xencor presented updated Phase 1 results for XmAb819 (ENPP3 x CD3 bi…
- Nov 10 to Nov 11 ▼ 2 days of insider sells: $3.6M by 2 insiders, avg $39.32
Signal stack
Where each data set points today.
- InsidersBEARISH
9 insiders sold $4.4M.
- InstitutionsBULLISH
Q3 2026: 21 added (1 new), 14 trimmed or exited.
- AnalystsBULLISH
17 of 20 rate it Buy or better. Median target $43.50 (+23%).
- EstimatesFALLING
Current-quarter EPS estimate −$0.775 → −$0.846 over 90 days. 2 up, 3 down in 30 days.
- Short sellersSTEADY
Short interest +5.1% to 12.90M shares. 6.6 days to cover, ≈17.2% of shares.
- TrendUPTREND
29% above its 50-day average. New closing high $39.97 on Nov 11.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Jefferies Financial Group Inc. | DOUBLED | $52.0M |
| Invesco Ltd. | DOUBLED | $21.7M |
| UBS Group AG | TRIM | $16.1M |
| PANAGORA ASSET MANAGEMENT INC | TRIM | $11.0M |
| HRT FINANCIAL LP | DOUBLED | $6.5M |
| RAYMOND JAMES FINANCIAL INC | ADD | $2.7M |
| Squarepoint Ops LLC | DOUBLED | $2.7M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | $2.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
20 analystsPrice is inside the target range. Median implies +23%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 5, 2026 | Cantor Fitzgerald REITERATE | Overweight |
| Oct 27, 2026 | Truist Securities MAINTAIN | Buy |
| Oct 27, 2026 | RBC Capital MAINTAIN | Outperform |
| Oct 27, 2026 | Wells Fargo MAINTAIN | Overweight |
| Oct 27, 2026 | Wedbush MAINTAIN | Outperform |
| Oct 26, 2026 | Cantor Fitzgerald MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Cornelissen Bart Jan SR. VICE PRESIDENT & CFO Nov 11, 2026 | SELL | $402.2K |
RANIERI RICHARD J Director Nov 10, 2026 | EXERCISE | $345.6K |
RANIERI RICHARD J Director Nov 10, 2026 | EXERCISE | $569.1K |
RANIERI RICHARD J Director Nov 10, 2026 | EXERCISE | $255.1K |
RANIERI RICHARD J Director Nov 10, 2026 | EXERCISE | $258.1K |
RANIERI RICHARD J Director Nov 10, 2026 | SELL | $2.7M |
RANIERI RICHARD J Director Nov 10, 2026 | SELL | $442.3K |
Feigal Ellen Director Jun 18, 2026 | SELL | $89.4K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.85 | -$1.30–-$0.12 | -3.3% | $31.3M |
| Next Q | -$0.96 | -$1.31–-$0.70 | -5.1% | $18.1M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
20 filings · 4 bullish · 3 bearish · 13 neutral- NEUTRAL SC 13G/ANov 16, 2026
Biotechnology Value Fund (BVF) group filed an amended Schedule 13G disclosing an aggregate deemed beneficial ownership of 6,227,034 shares (8.4%) of Xencor as of September 30, 2026, down from a prior 9.9% stake. The reduction reflects a decrease in BVF's direct holdings from 4.4% to 4.4%…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL SC 13GNov 13, 2026
Toronto-Dominion Bank disclosed a new passive 5.2% stake in Xencor Inc as of September 30, 2026…
TD Bank's new 5.2% passive stake adds a large, stable institutional holder to Xencor's base. Monitor future 13G amendments for any material increase or decrease; the passive certification makes…
- NEUTRAL CLUSTERNov 12, 2026
Two Xencor insiders, including the CFO, sold a combined $3.15M in open-market stock during the…
Insider sales are modest relative to market cap and follow a strong earnings beat, but the CFO's sale and the director's large derivative exercise/sale pattern warrant monitoring for any future…
- NEUTRAL 144Nov 12, 2026
Bart Jan Cornelissen, an officer of Xencor, filed a Form 144 notice to sell 10,100 shares of…
The filing is a routine insider intent-to-sell notice with no material impact. Monitor for any subsequent Form 4 filings to confirm execution, but no further action warranted.
All XNCR filing & press-release reports (20)
- SC 13G/A reportNov 16, 2026
- SC 13G reportNov 13, 2026
- CLUSTER reportNov 12, 2026
- 144 reportNov 12, 2026
- 144 reportNov 10, 2026
- SC 13G/A reportNov 6, 2026
- 8-K reportNov 4, 2026
- SC 13G/A reportOct 30, 2026
- SC 13G/A reportOct 27, 2026
- 8-K reportOct 26, 2026
- 8-K reportAug 5, 2026
- CLUSTER reportJun 17, 2026
- 144 reportJun 15, 2026
- 144 reportJun 15, 2026
- 8-K reportMay 6, 2026
- 8-K reportMay 5, 2026
- 8-K reportApr 27, 2026
- CLUSTER reportMar 5, 2026
- 8-K reportMar 4, 2026
- 8-K reportFeb 25, 2026